Answer
The most common adverse reactions in patients receiving Temodal (temozolomide) in clinical trials were nausea, vomiting, constipation, anorexia, headache, fatigue, convulsions and rash.
Sources for this answer
- Temodal CapsulesMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.8 Undesirable effects · Version 37Document updated
Sources checked